Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H29FO5 |
Molecular Weight | 392.4611 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
InChI
InChIKey=UREBDLICKHMUKA-CXSFZGCWSA-N
InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
R01AD03
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.4
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
CFR |
21 CFR 522.540
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
CFR |
21 CFR 520.540
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
CFR |
21 CFR 520.540A
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QD10AA03
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
674718
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
S01BA01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
S03BA01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
D07XB05
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QR01AD03
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QD07AB19
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QH02AB02
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
17.2
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
795620
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
NDF-RT |
N0000175576
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QS01CB01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QD07XB05
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
C05AA09
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
CFR |
21 CFR 520.540C
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
R01AD53
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
OZURDEX (AUTHORIZED: MACULAR EDEMA)
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QS02BA06
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ORZUDEX (AUTHORIZED: UVEITIS)
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QD07CB04
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
S03CA01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
S02BA06
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QS03CA01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
S01CA01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
626318
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QS01BA01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
115298
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
S02CA06
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QR01AD53
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.3
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
LIVERTOX |
288
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
CFR |
21 CFR 522.542
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
NCI_THESAURUS |
C267
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QS03BA01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
D07AB19
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QS01CA01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QC05AA09
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
NDF-RT |
N0000175450
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
S01CB01
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NEOFORDEX (AUTHORIZED: MULTIPLE MYELOMA)
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
H02AB02
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QA01AC02
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
CFR |
21 CFR 520.540B
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
A01AC02
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
D10AA03
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
03
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/10/763
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
CFR |
21 CFR 524.1484G
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QH02BX90
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
CFR |
21 CFR 520.563
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-ATC |
D07CB04
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
||
|
WHO-VATC |
QS02CA06
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DEXAMETHASONE
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
34521
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
5743
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
C422
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
7S5I7G3JQL
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
Dexamethasone, Topical
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
3053
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
m4215
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | Merck Index | ||
|
3264
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB01234
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
32132
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
DEXAMETHASONE
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | Description: Colourless crystals or a white or almost white, crystalline powder; odourless. Solubility: Practically insoluble in water; sparingly soluble in ethanol (~750 g/l) TS.Category: Adrenoglucocorticoid. Storage: Dexamethasone should be kept in a tightly closed container, protected from light. | ||
|
41879
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
Dexamethasone
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
824
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
1176007
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
7S5I7G3JQL
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
D003907
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
2768
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
DTXSID3020384
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
200-003-9
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
SUB07017MIG
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
50-02-2
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
CHEMBL384467
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
816
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY | |||
|
100000092605
Created by
admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
PRODRUG (METABOLITE ACTIVE)